Nolato AB (NOLA.B) AI Stock Analysis

• Market Cap: kr16.30B
• Dividend Yield: 2.44%
• Average Volume (3M): 192.26K
• Price to Earnings (P/E): 22.1
• Beta (1Y): 1.01
• Revenue Growth: 1.67%
• EPS Growth: 55.37%
• Country: SE
• Employees: 5,405
• Sector: Healthcare
• Sector Strength: 45
• Industry: Conglomerates
• EPS (TTM): N/A
• Shares Outstanding: 241,783,080
• 10 Day Avg. Volume: 144,118
• 30 Day Avg. Volume: 192,262
• PEG Ratio: 0.43
• Price to Book (P/B): 2.54
• Price to Sales (P/S): 1.51
• P/FCF Ratio: 19.68
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 73 Outperform
• Price Target: kr69.00 ▲(19.69% Upside)

Nolato AB's overall stock score reflects strong financial performance and positive technical indicators, supported by a positive earnings call. However, challenges in revenue growth and cash flow, along with a moderate valuation, temper the overall outlook.

Nolato AB Business Overview & Revenue Model

Company Description

Nolato AB (NOLA.B) is a Swedish company that operates in the advanced polymer solutions sector, specializing in the development and manufacturing of products made from silicone and thermoplastic materials. The company serves various industries, including medical technology, industrial, and consumer products. Nolato is known for its innovative solutions that enhance functionality and performance, focusing on areas like cleanroom manufacturing, healthcare applications, and custom molding processes.

How the Company Makes Money

Nolato AB generates revenue primarily through the production and sale of polymer-based products across its different business segments, which include Medical Solutions, Integrated Solutions, and Consumer Products. The Medical Solutions segment, which is a significant contributor to its revenue, focuses on manufacturing components and assemblies for the medical device industry, benefiting from long-term contracts and partnerships with major healthcare companies. The Integrated Solutions segment supplies customized solutions for various industrial applications, leveraging its expertise in polymer processing and design. Additionally, the Consumer Products segment provides products for personal care and hygiene markets. The company's revenue model is bolstered by its ability to innovate and adapt to customer needs, maintaining strong relationships with key clients and investing in research and development to create new products and improve existing ones.

Nolato AB Financial Statement Overview

Summary

Nolato AB exhibits robust financial health with strong revenue and profit growth, a solid balance sheet with no debt, and significant free cash flow generation. These factors reflect efficient operations, reduced financial risk, and potential for sustained growth.

Income Statement

Nolato AB has shown impressive revenue growth from 2023 to 2024, with a positive trajectory in gross profit and net income, reflecting strong operational performance. The gross profit margin improved to 16.69%, and the net profit margin increased to 6.81%, indicating enhanced profitability. EBIT and EBITDA margins also indicate robust operating efficiency. Overall, the company demonstrates solid revenue growth and profitability metrics, with room for further margin improvements.

Balance Sheet

The balance sheet of Nolato AB is strong, with a debt-free position contributing to stability. The equity ratio is high at 59.23%, indicating significant financial stability and low leverage risk. Return on equity has improved to 11.47%, showcasing efficient use of shareholder capital. The company has effectively managed its liabilities, reducing total debt to zero, thus minimizing financial risk.

Cash Flow

Cash flow analysis reveals excellent performance with significant free cash flow growth and strong operating cash flow. The free cash flow growth rate was substantial, and the operating cash flow to net income ratio of 2.09 indicates excellent cash generation relative to net income. The company's ability to generate free cash flow supports future investment opportunities and financial flexibility.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	9.63B	9.66B	9.55B	10.77B	11.61B	9.36B
Gross Profit	1.69B	1.61B	1.34B	1.43B	1.82B	1.51B
EBITDA	1.43B	1.52B	1.28B	1.48B	1.92B	1.46B
Net Income	738.00M	658.00M	435.00M	697.00M	1.16B	806.00M
Balance Sheet
Total Assets	9.32B	9.69B	9.30B	10.01B	10.05B	8.68B
Cash, Cash Equivalents and Short-Term Investments	476.00M	672.00M	688.00M	1.01B	1.45B	1.49B
Total Debt	1.71B	1.53B	1.88B	2.03B	1.79B	2.14B
Total Liabilities	4.03B	3.95B	4.13B	4.62B	5.29B	4.99B
Stockholders Equity	5.30B	5.74B	5.17B	5.39B	4.77B	3.70B
Cash Flow
Free Cash Flow	623.00M	742.00M	355.00M	-49.00M	446.00M	791.00M
Operating Cash Flow	1.26B	1.38B	781.00M	406.00M	1.23B	1.16B
Investing Cash Flow	-767.00M	-636.00M	-444.00M	-451.00M	-782.00M	-1.70B
Financing Cash Flow	-744.00M	-798.00M	-631.00M	-487.00M	-634.00M	730.00M

Nolato AB Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 57.65
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:NOLA.B, the sentiment is Positive. The current price of 57.65 is below the 20-day moving average (MA) of 59.25, below the 50-day MA of 59.06, and above the 200-day MA of 57.41, indicating a bullish trend. The MACD of 0.18 indicates Negative momentum. The RSI at 63.60 is Neutral, neither overbought nor oversold. The STOCH value of 89.20 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:NOLA.B.

Nolato AB Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
NOLA.B	―	kr16.30B	22.08	13.55%	2.44%	1.67%	55.37%
VIMIAN	―	€16.70B	47.26	4.63%	―	17.13%	―
MCAP	―	€8.35B	41.68	15.16%	―	11.30%	-14.49%
VITR	―	kr20.47B	46.40	3.34%	0.73%	-1.29%	―
ALIF.B	―	$22.32B	65.92	7.24%	0.37%	5.14%	236.75%
EKTA.B	―	kr19.10B	69.73	2.76%	4.81%	-1.54%	-75.84%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%

Nolato AB Corporate Events

Nolato AB Reports Strong Q3 2025 Performance and Strategic Expansion

Nolato AB reported a strong third quarter in 2025, with an increase in operating profit and EBITA margin, driven by strategic price and cost adjustments. The company continues to focus on organic growth and expanding its global footprint, particularly in Asia, while maintaining a strong financial position that supports future investments and acquisitions.

The most recent analyst rating on ($SE:NOLA.B) stock is a Hold with a SEK62.00 price target. To see the full list of analyst forecasts on Nolato AB stock, see the SE:NOLA.B Stock Forecast page.

Nolato AB to Release Q3 2025 Interim Report with Webcast Conference

Nolato AB announced it will release its interim report for the third quarter of 2025 on October 28, followed by a webcast conference call. This event will feature presentations by the President and CEO, Christer Wahlquist, and CFO, Per-Ola Holmström, who will discuss the report and answer questions. The announcement indicates Nolato’s commitment to transparency and engagement with stakeholders, potentially impacting its market perception and investor relations.

The most recent analyst rating on ($SE:NOLA.B) stock is a Hold with a SEK62.00 price target. To see the full list of analyst forecasts on Nolato AB stock, see the SE:NOLA.B Stock Forecast page.